Neil Clark
Keine laufenden Positionen mehr
Profil
Neil R.
Clark served as the Chief Executive Officer of CeNeS Pharmaceuticals Plc from 1997 to 2009.
He then worked as the Secretary & Executive Director of Ergomed Plc from 2009 to 2017.
In 2016, he became the Chief Executive Officer of PrimeVigilance Ltd.
From 2017 to 2023, he served as the Chief Executive Officer & Executive Director of Destiny Pharma Plc.
Prior to his career in the pharmaceutical industry, he worked as an accountant at PricewaterhouseCoopers LLP.
Mr. Clark obtained an undergraduate degree from The University of Nottingham.
Ehemalige bekannte Positionen von Neil Clark
| Unternehmen | Position | Ende |
|---|---|---|
| DESTINY PHARMA PLC | Chief Executive Officer | 25.05.2023 |
| ERGOMED | Director of Finance/CFO | 11.01.2016 |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Other Consumer ServicesConsumer Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
PrimeVigilance Ltd.
 PrimeVigilance Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ergomed Plc, PrimeVigilance Ltd. is a British company that provides medical information. The private company is based in Guildford, UK. The company was founded in 2008 by Miroslav Reljanovic. PrimeVigilance was acquired by Ergomed Plc on July 09, 2014 for $15.11 million. | Chief Executive Officer | 16.04.2017 |
CeNeS Pharmaceuticals Plc
 CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Chief Executive Officer | - |
Ausbildung von Neil Clark
| The University of Nottingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DESTINY PHARMA PLC | Health Technology |
| ERGOMED | Commercial Services |
| Private Unternehmen | 3 |
|---|---|
CeNeS Pharmaceuticals Plc
CeNeS Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology CeNeS Pharmaceuticals Plc engages in the discovery and development of drugs. The company was founded by Alan Gilbert Goodman in 1997 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
PricewaterhouseCoopers LLP (United Kingdom)
PricewaterhouseCoopers LLP (United Kingdom) Other Consumer ServicesConsumer Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Consumer Services |
PrimeVigilance Ltd.
PrimeVigilance Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ergomed Plc, PrimeVigilance Ltd. is a British company that provides medical information. The private company is based in Guildford, UK. The company was founded in 2008 by Miroslav Reljanovic. PrimeVigilance was acquired by Ergomed Plc on July 09, 2014 for $15.11 million. | Commercial Services |
